Susan Pfefferle to Antibodies, Viral
This is a "connection" page, showing publications Susan Pfefferle has written about Antibodies, Viral.
Connection Strength
0.368
-
Pfl?ger LS, Bannasch JH, Brehm TT, Pfefferle S, Hoffmann A, N?rz D, van der Meirschen M, Kluge S, Haddad M, Pischke S, Hiller J, Addo MM, Lohse AW, Schulze Zur Wiesch J, Peine S, Aepfelbacher M, L?tgehetmann M. Clinical evaluation of five different automated SARS-CoV-2 serology assays in a cohort of hospitalized COVID-19 patients. J Clin Virol. 2020 09; 130:104549.
Score: 0.143
-
Reisinger EC, von Possel R, Warnke P, Geerdes-Fenge HF, Hemmer CJ, Pfefferle S, L?bermann M, Littmann M, Emmerich P. [Screening of Mothers in a COVID-19 Low-Prevalence Region: Determination of SARS-CoV-2 Antibodies in 401 Mothers from Rostock by ELISA and Confirmation by Immunofluorescence]. Dtsch Med Wochenschr. 2020 08; 145(17):e96-e100.
Score: 0.143
-
Olearo F, Radmanesh LS, Felber N, von Possel R, Emmerich P, Pekarek N, Pfefferle S, N?rz D, Hansen G, Diemert A, Aepfelbacher M, Hecher K, L?tgehetmann M, Arck PC, Tallarek AC. Anti-SARS-CoV-2 antibodies in breast milk during lactation after infection or vaccination: A cohort study. J Reprod Immunol. 2022 09; 153:103685.
Score: 0.041
-
Brehm TT, Pfefferle S, von Possel R, Karolyi M, Zoufaly A, Wichmann D, Kobbe R, Emmerich P, N?rz D, Aepfelbacher M, Schulze Zur Wiesch J, Addo MM, Schmiedel S, L?tgehetmann M. Clinical efficacy and in vitro neutralization capacity of monoclonal antibodies for severe acute respiratory syndrome coronavirus 2 delta and omicron variants. J Med Virol. 2022 10; 94(10):5038-5043.
Score: 0.041